 |
 |

Predictive Factors for Metastatic Involvement of Nonsentinel Nodes in Patients With Breast Cancer
Frans D. Rahusen, MD;
Hans Torrenga, MD;
Paul J. van Diest, MD,PhD;
Rik Pijpers, MD,PhD;
Elsken van der Wall, MD,PhD;
Jappe Licht, MS;
Sybren Meijer, MD,PhD
Arch Surg. 2001;136:1059-1063.
Background The potential morbidity of an axillary lymph node dissection in patients with breast cancer can be avoided in patients with a negative sentinel node (SN).
Hypothesis It may be possible to identify a subset of patients with a positive SN and without metastases in the remaining axillary lymph nodes.
Design Case-control study.
Setting Both primary and referral hospital care.
Patients Data were studied for 255 consecutive patients with stage T1 or T2 breast cancer who had a successful identification of the SN.
Interventions In patients with a positive SN, histological examination of all non-SNs that were negative by routine examination was the same as that for SNs (multiple sectioning and immunohistochemical analysis).
Main Outcome Measures The incidence of non-SN metastases was correlated with the surface area and number of SN metastases and primary tumor characteristics. A micrometastasis was defined as less than 1 mm2.
Results Of 255 patients, the SN appeared to be positive in 93 (36%). Subsequent axillary lymph node dissection revealed positive non-SNs in 46 patients (49%). Patients with a single positive SN and patients with metastases less than 1 mm2 in the SN had significantly less non-SN involvement than patients with more than 1 positive SN (40% vs 78%) and patients with macrometastases (27% vs 49%).
Conclusions The incidence of non-SN metastases seemed to be related to the number of positive SNs and the size of SN metastases. However, in the group of patients with a positive SN, it was not possible to identify a subset of patients without non-SN metastases.
From the Departments of Surgical Oncology (Drs Rahusen, Torrenga, and Meijer), Pathology (Dr van Diest and Mr Licht), Nuclear Medicine (Dr Pijpers), and Oncology (Dr van der Wall), Vrije Universiteit Medical Center, Amsterdam, the Netherlands.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2001;136(9):1089-1090.
FULL TEXT
This Month in Archives of Surgery
Arch Surg. 2001;136(9):986.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Impact and Remaining Challenges in the Use of Sentinel Lymph Node Biopsy in Early-stage Breast Cancer
Lyman et al.
Am Soc Clin Oncol Ed Book 2009;2009:346-353.
ABSTRACT
| FULL TEXT
Application of intraoperative ultrasound to nonsentinel node assessment in primary breast cancer.
Hsu et al.
Clin. Cancer Res. 2006;12:3746-3753.
ABSTRACT
| FULL TEXT
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Lyman et al.
JCO 2005;23:7703-7720.
ABSTRACT
| FULL TEXT
Axillary Sentinel Node and Tumour-related Factors Associated with Non-sentinel Node Involvement in Breast Cancer
Cserni et al.
Jpn J Clin Oncol 2004;34:519-524.
ABSTRACT
| FULL TEXT
Supervised automated microscopy increases sensitivity and efficiency of detection of sentinel node micrometastases in patients with breast cancer
Mesker et al.
J. Clin. Pathol. 2004;57:960-964.
ABSTRACT
| FULL TEXT
Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates
McCready et al.
JNCI J Natl Cancer Inst 2004;96:873-875.
ABSTRACT
| FULL TEXT
Factors affecting metastases to non-sentinel lymph nodes in breast cancer
Fleming et al.
J. Clin. Pathol. 2004;57:73-76.
ABSTRACT
| FULL TEXT
Nonvisualization of Axillary Sentinel Node During Lymphoscintigraphy: Is There a Pathologic Significance in Breast Cancer?
Brenot-Rossi et al.
JNM 2003;44:1232-1237.
ABSTRACT
| FULL TEXT
Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies
Jakub et al.
The Oncologist 2003;8:59-68.
ABSTRACT
| FULL TEXT
Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients
Cserni
J. Clin. Pathol. 2002;55:926-931.
ABSTRACT
| FULL TEXT
Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance
den Bakker et al.
J. Clin. Pathol. 2002;55:932-935.
ABSTRACT
| FULL TEXT
Sentinel lymph node biopsy in breast cancer
Bonnema and van de Velde
Ann Oncol 2002;13:1531-1537.
ABSTRACT
| FULL TEXT
Sentinel nodal assessment in patients with carcinoma of the lung
Schmidt et al.
Ann. Thorac. Surg. 2002;74:870-875.
ABSTRACT
| FULL TEXT
|